News
Australia's securities regulator said on Tuesday it would trial changes to speed up initial public offerings that are at a ...
Slide Insurance Holdings Inc. and some of its investors are seeking to raise $340 million in an initial public offering, ...
(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in ...
Insurance tech company Slide is aiming for a valuation of up to $2.12 billion in its U.S. initial public offering, joining a ...
IPO offers diversified exposure to newly public companies, with a balanced mix of value, blend, and growth. Read why I'm ...
Sacheerome IPO opened on June 9 and closes June 11, with shares priced between ₹96 and ₹102. The retail portion was ...
Lenskart has converted to a public entity as it prepares for a potential $1-billion IPO, aiming for a $10 billion valuation.
The trial measures will accelerate listings and represent the biggest changes to the process for almost a decade.
Chairman Joe Longo cannot fix the fact private markets will pay more for smaller businesses than public markets, but he can ...
Get the latest on the Sacheerome IPO including grey market premium (GMP), expected listing price, and probable listing date.
The chronic condition management company’s debut comes weeks after another digital health company, Hinge Health, went public.
Piyush Bansals eyewear brand, Lenskart, has been renamed to Lenskart Solution Limited From Lenskart Solution Private Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results